BRANDON BALLARD: Open Payments
NPI 1962739516 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,034 in 161 payments from 21 companies in 2025. Trend: 2023 $1,323 · 2024 $1,933 · 2025 $3,034
Food & beverage: $3,034
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $749 |
| Aimmune Therapeutics, Inc. | 21 | $322 |
| Madrigal Pharmaceuticals | 11 | $237 |
| PFIZER INC. | 17 | $214 |
| Phathom Pharmaceuticals, Inc. | 9 | $206 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $162 |
| GENZYME CORPORATION | 6 | $155 |
| Ardelyx, Inc. | 9 | $152 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $148 |
| Regeneron Healthcare Solutions, Inc. | 5 | $134 |
Products named: RINVOQ, ZENPEP, DUPIXENT, REZDIFFRA, VOQUEZNA, SKYRIZI, IBSRELA, ENTYVIO.
Industry payments across NC — which companies pay providers there.
